{"data":{"id":"us-in/ic-16-42-26-4","jurisdiction":"us-in","citation":"IC 16-42-26-4","heading":"Availability of investigational drug, biological product, or device","body":"Sec. 4. (a) A manufacturer of an investigational drug, biological product, or device may make available the investigational drug, biological product, or device to a qualified patient.\n(b) A manufacturer may do any of the following:\n(1) Provide an investigational drug, biological product, or device to a qualified patient without receiving compensation.\n(2) Require a qualified patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 26. Drugs: Investigational Drug, Biological Product, or Device"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-26-4","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"29e44e2f303a22078b8a1418de4d99207e7b4157a55098f27992b52b7cdfb661","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-26-3","next":"us-in/ic-16-42-26-5"},"notice":"GroundRules: Original legal text. Not legal advice."}